In an effort to enhance antitumor and anti-metastasis of breast cancer, honokiol (HNK) was encapsulated into hyaluronic acid (HA) modified cationic liposomes (Lip). The prepared HA-Lip-HNK had a spherical shape with a narrow size distribution. The enhanced antitumor efficacy of HA-Lip-HNK was investigated in 4T1 cells in vitro, wherein flow cytometry and confocal microscopy analysis revealed its HA/CD44-mediated greater cellular internalization. As anticipate, the significant cytotoxicity of the HA-Lip-HNK was also observed in 4T1 tumor spheroids. Furthermore, the superior prevention of tumor metastasis by HA-Lip-HNK was verified by in vitro anti-invasion, wound healing and anti-migration assessments, and in vivo bioluminescence imaging in pulmonary metastasis model. Finally, compared with unmodified liposomes, the HA-Lip-HNK exhibited higher tumor accumulation, and achieved a tumor growth inhibition rate of 59.5 %. As a result, the HA-Lip-HNK may serve as a promising tumor-targeted drug delivery strategy for the efficient therapy of metastatic breast cancer. In this study, Response Surface Methodology was used to optimize the electrospinning process parameters including voltage, distance, and flow rate in order to obtain catechin-loaded electrospun nanofibers from Azivash (Corchorus olitorius. L) gum-polyvinyl alcohol with the minimum diameter of nanofibers. The optimum electrospinning conditions were applied for catechin encapsulation at different loading concentrations (500, 1000, 2000 and 3000 mg L-1). According to the results, increase in catechin concentration led to increment in polymer solution viscosity. However, electrical conductivity decreased and mean diameter of nanofibers increased from 89 nm to 371 nm. There was a robust interaction between the catechin and polymer matrix; also addition of catechin improved thermal stability of nanofibers. In general, at higher catechin levels, despite increasing loading capacity, encapsulation efficiency was significantly reduced (p  less then  0.05). Optimum nanofibers loaded with 500 and 1000 mg L-1 catechin can be considered to apply in active food packaging and pharmaceutical applications. The polysaccharide PGO containing 76 % of uronic acids, was obtained from peels and membranes of Punica granatum fruits by extraction to the aqueous solution of (NH4)2C2O4. The chemical structure of PGO was characterized by enzymatic and partial acid hydrolyses, Smith degradation and 1D/2D NMR spectroscopy. It has been found that PGO consisted mainly of highly methyl-esterified and lowly acetylated pectin. Backbone of the macromolecule was represented by 1,4-α-D-GalpA, 1,4-α-D-GalpA(OMe), 1,4-α-D-GalpA(OAc). The branched region PGO contained minor segments of partially acetylated rhamnogalacturonan-I (RG-I). RG-I side chains were comprised of highly branched 1,5-α-l-arabinan and segments of arabinogalactan type I. In addition to pectins, PGO contained the glucuronoxylans and xyloglucans, indicating a close interaction of these polysaccharides with each other in the cell wall. It was concluded that P. granatum fruit could be a promising source of pectic polysaccharides. Exopolysaccharide (R-5-EPS) was isolated from the fermented milk of Lactobacillus helveticus LZ-R-5 and purified by DEAE-52 cellulose anion-exchange column, and characterization of the structure was conducted. Results showed that R-5-EPS was a heteropolysaccharide containing linear repeating units of →6)-β-D-Galp-(1→3)-β-D-Glcp-(1→3)-β-D-Glcp-(1→3)-β-D-Glcp-(1→3)-β-D-Glcp-(1→ with an average Mw of 5.41 × 105 Da. Furthermore, at a cellular level, R-5-EPS showed immunostimulatory activity due to its strong effect on increasing proliferation of RAW264.7 macrophages and enhancing phagocytosis, acid phosphatase activity, nitric oxide production and cytokines production in macrophages. These results suggest that R-5-EPS have a potent immunostimulatory activity and may be explored as a potential immunomodulatory agent. Chitosan-based membranes were prepared via electrospinning technique using a low concentrated acetic acid solution as solvent and poly(ethylene oxide) as co-spinning agent. Different solutions were rheologically characterized and increasing the solution viscosity was found to correspond to a better-defined morphology. The membranes were first subjected to a coagulation process with different baths in order to stabilize chitosan and the mats were found not able to withstand a strongly basic environment. Subsequently, a physical and a chemical crosslinking approach were separately optimized to obtain stable mats whose composition was assessed via thermogravimetric and spectroscopic techniques, proving in both cases the elimination of the co-spinning agent. https://www.selleckchem.com/products/mk571.html Above all, the ionically crosslinked mats represent a class of extremely promising biomedical products being probably highly biocompatible and characterized by thin and homogenous nanofibers with a diameter of 200 nm, thus showing the ideal structure to foster cell viability. The control of blood flow from breached blood vessels during surgery or trauma is challenging. With the existing treatment options being either expensive or ineffective, the development of a haemostat that overcome such drawbacks would be beneficial. With an aim to develop an ideal haemostat, the potential of sodium starch glycolate (SSG), a commonly used pharmaceutical disintegrant was modified to obtain porous microparticles (pSSG). The biodegradability, cyto-compatibility and haemo-compatibility of the modified particles were confirmed using appropriate studies. In comparison to starch and SSG, the irregular shaped pSSG demonstrated spontaneous and significant fluid absorption (3500+500 %) and formed a physical barrier to blood flow. In addition, significant blood cells aggregation and platelet activation was observed in the modified micoparticles leading to rapid clot formation. In-vivo studies on liver and abdominal artery injury models in rats indicated the superior haemostatic potential of pSSG over SSG and starch. The results indicated that pSSG can be explored further in clinical evaluation as a hemostat.